Literature DB >> 10074104

Differential cell tropism of feline immunodeficiency virus molecular clones in vivo.

G A Dean1, S Himathongkham, E E Sparger.   

Abstract

Independent studies have demonstrated different cell tropisms for molecular clones of feline immunodeficiency virus (FIV). In this report, we examined three clones, FIV-pF34, FIV-14, and FIV-pPPR, for replication in Crandell feline kidney (CrFK) cells, feline peripheral blood mononuclear cells (PBMC), and feline macrophage cultures. Importantly, cell tropism for these three clones was also examined in vivo. FIV-pF34 replication was efficient in CrFK cells but severely restricted in PBMC, whereas replication of FIV-pPPR was vigorous in PBMC but severely restricted in CrFK cells. FIV-14 replication was productive in both CrFK cells and PBMC. Interestingly, all three molecular clones replicated with similar efficiencies in primary feline monocyte-derived macrophages. In vivo, FIV-pF34 proved least efficient for establishing persistent infection, and proviral DNA when detectable, was localized predominately to nonlymphoid cell populations (macrophages). FIV-pPPR proved most efficient for induction of a persistent viremia in vivo, and proviral DNA was localized predominately in CD4(+) and CD8(+) lymphocyte subsets. FIV-14 inoculation of cats resulted in an infection characterized by seroconversion and localization of proviral DNA in CD4(+) lymphocytes only. Results of this study on diverse FIV molecular clones revealed that in vitro replication efficiency of an FIV isolate in PBMC directly correlated with replication efficiency in vivo, whereas proficiency for replication in macrophages in vitro was not predictive for replication potential in vivo. Also, infection of both CD4(+) and CD8(+) lymphocyte subsets was associated with higher virus load in vivo. Results of the studies on these three FIV clones, which exhibited differential cell tropism, indicated a correlation between in vitro and in vivo cell tropism and virus replication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074104      PMCID: PMC104014     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Comparison of two host cell range variants of feline immunodeficiency virus.

Authors:  T R Phillips; R L Talbott; C Lamont; S Muir; K Lovelace; J H Elder
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections.

Authors:  J E Barlough; C D Ackley; J W George; N Levy; R Acevedo; P F Moore; B A Rideout; M D Cooper; N C Pedersen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

3.  Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus.

Authors:  D Brunner; N C Pedersen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

4.  An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus.

Authors:  A L Edinger; T L Hoffman; M Sharron; B Lee; Y Yi; W Choe; D L Kolson; B Mitrovic; Y Zhou; D Faulds; R G Collman; J Hesselgesser; R Horuk; R W Doms
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor.

Authors:  R Collman; B Godfrey; J Cutilli; A Rhodes; N F Hassan; R Sweet; S D Douglas; H Friedman; N Nathanson; F Gonzalez-Scarano
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.

Authors:  M Tersmette; R A Gruters; F de Wolf; R E de Goede; J M Lange; P T Schellekens; J Goudsmit; H G Huisman; F Miedema
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  Variation of HIV infectibility of macrophages as a function of donor, stage of differentiation, and site of origin.

Authors:  K Olafsson; M S Smith; P Marshburn; S G Carter; S Haskill
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

8.  Molecular cloning of feline immunodeficiency virus.

Authors:  R A Olmsted; A K Barnes; J K Yamamoto; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Nucleotide sequence and genomic organization of feline immunodeficiency virus.

Authors:  R L Talbott; E E Sparger; K M Lovelace; W M Fitch; N C Pedersen; P A Luciw; J H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Biologic features of HIV-1 that correlate with virulence in the host.

Authors:  C Cheng-Mayer; D Seto; M Tateno; J A Levy
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

View more
  21 in total

1.  During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.

Authors:  M Bendinelli; M Pistello; D Del Mauro; G Cammarota; F Maggi; A Leonildi; S Giannecchini; C Bergamini; D Matteucci
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

3.  Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.

Authors:  L Bigornia; K M Lockridge; E E Sparger
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.

Authors:  J B Johnston; C Power
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.

Authors:  Malou C Gemeniano; Earl T Sawai; Christian M Leutenegger; Ellen E Sparger
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.

Authors:  Magnus Sundstrom; Rebecca L White; Aymeric de Parseval; K Jagannadha Sastry; Garrett Morris; Chris K Grant; John H Elder
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

7.  Infection of the choroid plexus by feline immunodeficiency virus.

Authors:  D C Bragg; T A Childers; M B Tompkins; W A Tompkins; R B Meeker
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

8.  Immunohistochemical localization of feline immunodeficiency virus using native species antibodies.

Authors:  Arlin B Rogers; Candace K Mathiason; Edward A Hoover
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

9.  Viral gene expression and provirus load of Orf-A defective FIV in lymphoid tissues and lymphocyte subpopulations of neonatal cats during acute and chronic infections.

Authors:  Janelle M Novak; P Cynthia Crawford; Holly M Kolenda-Roberts; Calvin M Johnson; Ayalew Mergia
Journal:  Virus Res       Date:  2007-07-17       Impact factor: 3.303

10.  Replacement of the V3 domain in the surface subunit of the feline immunodeficiency virus envelope glycoprotein with the equivalent region of a T cell-tropic human immunodeficiency virus type 1 results in a chimeric surface protein that efficiently binds to CXCR4.

Authors:  Silvia A González; Juan I Falcón; José L Affranchino
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-12       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.